Stocks and Investing
Stocks and Investing
Mon, November 14, 2016
[ 07:46 AM ] - United States, WOPRAI
[ 07:46 AM ] - United States, WOPRAI
[ 07:46 AM ] - United States, WOPRAI
[ 07:46 AM ] - United States, WOPRAI
[ 07:46 AM ] - United States, WOPRAI
[ 07:46 AM ] - United States, WOPRAI
[ 07:46 AM ] - United States, WOPRAI
[ 07:46 AM ] - United States, WOPRAI
[ 07:46 AM ] - United States, WOPRAI
[ 07:46 AM ] - United States, WOPRAI
[ 07:45 AM ] - United States, WOPRAI
[ 07:45 AM ] - United States, WOPRAI
[ 07:45 AM ] - United States, WOPRAI
[ 07:45 AM ] - United States, WOPRAI
[ 07:45 AM ] - United States, WOPRAI
[ 07:45 AM ] - United States, WOPRAI
[ 07:45 AM ] - United States, WOPRAI
[ 05:45 AM ] - United States, WOPRAI
[ 01:46 AM ] - United States, WOPRAI
[ 01:45 AM ] - United States, WOPRAI
[ 01:45 AM ] - United States, WOPRAI
[ 01:45 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Douglas Tsao Initiated (TEVA) at Hold and Held Target at $46 on, Nov 14th, 2016
Douglas Tsao of Barclays, Initiated "Teva Pharmaceutical Industries Limited" (TEVA) at Hold and Held Target at $46 on, Nov 14th, 2016.
Douglas has made no other calls on TEVA in the last 4 months.
There are 6 other peers that have a rating on TEVA. Out of the 6 peers that are also analyzing TEVA, 2 agree with Douglas's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Sumant Kulkarni of "B of A Securities" Downgraded from Strong Buy to Hold on, Monday, November 7th, 2016
- Irina Rivkind Koffler of "Mizuho" Downgraded from Strong Buy to Hold on, Monday, October 24th, 2016
These are the ratings of the 4 analyists that currently disagree with Douglas
- Vamil Divan of "Credit Suisse" Upgraded from Hold to Buy on, Monday, October 31st, 2016
- Derek Archila of "Oppenheimer" Upgraded from Hold to Buy on, Friday, September 2nd, 2016
- Ami Fadia of "Leerink Swann" Maintained at Buy with Decreased Target to $61 on, Wednesday, August 31st, 2016
- Tim Chiang of "BTIG" Maintained at Strong Buy and Held Target at $75 on, Wednesday, August 24th, 2016
Contributing Sources